Quipt Home Medical Corp. (NASDAQ:QIPT) Q3 2022 Results Conference Call August 16, 2022 10:00 AM ET
Company Participants
Greg Crawford - Chairman and Chief Executive Officer
Hardik Mehta - Chief Financial Officer
Thomas Roehrig - Executive Vice President of Finance
Conference Call Participants
Doug Cooper - Beacon Securities
Sepehr Manochehry - Eight Capital
Rahul Sarugaser - Raymond James
Paul Stewardson - iA Capital Markets
Justin Keywood - Stifel
Stefan Quenneville - Echelon Capital Markets
Operator
Thank you for standing by. This is the conference operator. Welcome to the Fiscal Third Quarter Results Conference Call for Quipt Home Medical Corp. As a reminder, all participants are in a listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity for analyst to ask questions. [Operator Instructions]
We remind you that our remarks today will include forward-looking statements that are subject to important risks and uncertainties. For more information on these risks and uncertainties, please see the reader advisory at the bottom of the Company's results news release as well as MD&A, which you can find on SEDAR and EDGAR. The Company's actual performance could differ materially from these statements.
At this point, I'd like to turn the call over to Chairman and Chief Executive Officer, Greg Crawford.
Greg Crawford
Thank you, operator, and thank you all for joining us today on the call. My name is Greg Crawford, and I'm the Chairman and Chief Executive Officer of Quipt Home Medical. Joining me today is Hardik Mehta, our Chief Financial Officer, and Thomas Roehrig, our Executive Vice President of Finance.
On the heels of another record quarter showcasing continued operational excellence, which produced 2% sequential organic growth and strong margin stability. I would like to begin today's call by extending my gratitude to over 800 dedicated Quipt team members across 19 states, serving over 200,000 active patients. It is their tireless efforts every day that are making us a award winning leader in clinical respiratory care across the country. It is extremely clear to us that offering a whole suite of end-to-end respiratory products and not being single threaded into a particular category has been a key reason for our continued success and is a leading factor for our strong growth in our key markets.
Our team has been focused on executing our strategic vision of expanding into a national provider of at-home respiratory services. As we have progressed through 2022, we have continued to see significant progress made. We have expanded our organizational capabilities, continuing to grow our employee base with additional talented new team members at each facet of the Company, including many vital corporate functions.